Prognia
Drug Database
🇺🇸US · FDA ApprovedDiscontinuedANDA040109-001

ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE(ACETAMINOPHEN)

Manufacturer: MIKART

FDA Approval: 26/08/1997

Route: ORAL · CAPSULE

Active Ingredients

ACETAMINOPHEN 356.4MG; CAFFEINE 30MG; DIHYDROCODEINE BITARTRATE 16MG

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE — check interactions with your patient's full medication list, get dosing recommendations with renal/hepatic adjustments, and explore guideline-cited evidence.

Medical disclaimer: This drug information is intended for qualified healthcare professionals only. Always verify with the official FDA prescribing information before clinical use.